secwatch.observer — SEC 8-K summary
======================================

Issuer:     Lineage Cell Therapeutics, Inc. (LCTX)
CIK:        0000876343
Form:       8-K/A
Filed at:   2022-09-30T23:59:59+00:00
Accession:  0001493152-22-027295
Event type: other
Sentiment:  neutral
Materiality: 0.10
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

Lineage Cell corrects CEO salary to $609k in amended employment agreements
--------------------------------------------------------------------------

- Corrects CEO Brian Culley's base annual salary from $690,000 to $609,000.
- Corrects cash severance payment method: installments for termination without cause/good reason, lump sum only within change-of-control window.
- Other terms unchanged: Samuel salary $394,800, Hogge $366,800; bonus targets 55%, 40%, 35% respectively.
- Board adopted Executive Performance Incentive Bonus Plan (as originally disclosed).

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/876343/000149315222027295/0001493152-22-027295-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/876343/000149315222027295/form8-ka.htm
  HTML page:      https://secwatch.observer/filing/0001493152-22-027295

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer